Core Viewpoint - Chengdu Xiandai (688222) announced an investment of 40 million yuan in MoSheng Intelligent Technology (Chengdu) Co., Ltd., acquiring a 51% stake, which will be consolidated into Chengdu Xiandai's financial statements [1] Group 1: Investment Details - The investment will be made through the Chengdu Rongchuang Xiandai Equity Investment Fund Partnership (Limited Partnership) [1] - After the investment, the target company MoSheng Intelligent will be included in Chengdu Xiandai's consolidated financial statements [1] Group 2: Fund Structure - Chengdu Xiandai holds a 40% stake in the Rongchuang Xiandai Fund as a limited partner [1] - The fund's investment focus includes life science data infrastructure, AI model development, and pharmaceutical consulting services [1]

Group 1 - Chengdu Xian Dao (688222.SH) announced an investment of 40 million yuan in MoSheng Intelligent Technology (Chengdu) Co., Ltd. through the Rong Chuang Xian Dao Fund, which is partially funded by the company [1] - After the investment, the Rong Chuang Xian Dao Fund will hold a 51% stake in MoSheng Intelligent, which will be included in Chengdu Xian Dao's consolidated financial statements [1] Group 2 - MoSheng Intelligent focuses on life sciences data infrastructure, AI model development, and pharmaceutical consulting services [2] - The company has three subsidiaries: MoSheng Data Science (Chengdu) Pharmaceutical Technology Co., Ltd., Hydrocarbon Data Science (Chengdu) Information Technology Co., Ltd., and MoSheng Data Science (Chongqing) Information Technology Co., Ltd. [2] - MoSheng Data Science (Chengdu) is the core platform established in 2020, specializing in data services and AI solutions in the life sciences sector, covering investment, project initiation, research and development, registration, production, sales, and medical services [2] - The company has received multiple certifications, including high-tech enterprise and provincial "specialized and innovative" enterprise [2]